ACTU Actuate Therapeutics
- 9.020
- +0.050+0.56%
- 9.150
- +0.130+1.44%
Actuate Therapeutics News
Actuate Therapeutics | 4/A: Statement of changes in beneficial ownership of securities (and amendment thereto)-Director Bios Equity COF, LP
Actuate Therapeutics | 4/A: Statement of changes in beneficial ownership of securities (and amendment thereto)-Director Fletcher Aaron G.L.
Actuate Therapeutics | 4/A: Statement of changes in beneficial ownership of securities (and amendment thereto)-10% Owner Kreis Leslie W.
Actuate Therapeutics | SC 13D: Statement of acquisition of beneficial ownership by individuals-AARON GLENN LOUIS FLETCHER(52.8%),BIOS CAPITAL MANAGEMENT, LP(52.4%), etc.
Actuate Therapeutics | 4: Statement of changes in beneficial ownership of securities-Director THOMSON TODD S
Actuate Therapeutics | 4: Statement of changes in beneficial ownership of securities-Director Bios Equity COF, LP
Actuate Therapeutics | 4: Statement of changes in beneficial ownership of securities-Director Bios Equity COF, LP
Actuate Therapeutics | 4: Statement of changes in beneficial ownership of securities-Director Fletcher Aaron G.L.
Actuate Therapeutics | 4: Statement of changes in beneficial ownership of securities-Director Fletcher Aaron G.L.
Actuate Therapeutics | 4: Statement of changes in beneficial ownership of securities-10% Owner Kreis Leslie W.
Actuate Therapeutics | 4: Statement of changes in beneficial ownership of securities-10% Owner Kreis Leslie W.
Actuate Therapeutics | 3: Initial statement of beneficial ownership of securities-Director Bios 2024 Co-Invest, LP
Actuate Therapeutics | 4: Statement of changes in beneficial ownership of securities-Director Zabrowski Dan
Actuate Therapeutics | 4: Statement of changes in beneficial ownership of securities-Officer SCHMITT DANIEL M
Actuate Therapeutics | 4: Statement of changes in beneficial ownership of securities-Officer LYTLE PAUL J
Actuate Therapeutics | 4: Statement of changes in beneficial ownership of securities-Director Keyes Jason A
Actuate Therapeutics | 4: Statement of changes in beneficial ownership of securities-Director RONNEBERG AMY L
Actuate Therapeutics | 4: Statement of changes in beneficial ownership of securities-Director Sawhney Roger
Actuate Therapeutics | 3: Initial statement of beneficial ownership of securities-Director RONNEBERG AMY L
Actuate Therapeutics | 3: Initial statement of beneficial ownership of securities-Director Sawhney Roger
Analysis
Price Target
No Data
No Data
